Healthcare Data Leader H1 Releases Its Top Predictions for 2023
December 07, 2022 09:00 ET
|
H1
NEW YORK, Dec. 07, 2022 (GLOBE NEWSWIRE) -- H1, the connecting force for global healthcare provider, clinical, science, and research information, today released its predictions for 2023 to help life...
China Cell Therapy Market Opportunity & Clinical Trials Report 2022-2028: Insight on More Than 25 Cell Therapies Proprietary Technologies Developed By Chinese Companies
December 05, 2022 04:03 ET
|
Research and Markets
Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "China Cell Therapy Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. China has...
CenExel CNS Opens Center in Los Alamitos, California
November 30, 2022 11:31 ET
|
CenExel Clinical Research
Los Alamitos, California, Nov. 30, 2022 (GLOBE NEWSWIRE) -- CenExel CNS announces the grand opening of the newest clinical research facility in Los Alamitos, California. CenExel CNS has been...
Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies
November 22, 2022 08:00 ET
|
Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) takes exception to a recent study published in the New England Journal of...
Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies
November 22, 2022 08:00 ET
|
Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) takes exception to a recent study published in the New England Journal of...
CenExel Creates Clinical Sciences Business Unit
November 15, 2022 15:14 ET
|
CenExel Clinical Research
Salt Lake City, Utah, Nov. 15, 2022 (GLOBE NEWSWIRE) -- CenExel announces a new Clinical Sciences business unit, composed of early phase and translational medicine scientists, plus the broader...
First of its Kind Head-to-Head Study Comparing Leading Biomarkers for Detecting Alzheimer’s Disease Closes With Unprecedented Representation from Underrepresented Populations
November 15, 2022 06:00 ET
|
Global Alzheimer's Platform Foundation
WASHINGTON, DC, Nov. 15, 2022 (GLOBE NEWSWIRE) -- In 18 months, the Global Alzheimer’s Platform Foundation (GAP) recruited more than 1,000 participants to enroll in the first-ever head-to-head study...
Grant for High-Risk, High-Impact Brain Cancer Research Awarded to Ivy Center Investigator
November 10, 2022 09:00 ET
|
Ivy Brain Tumor Center
Phoenix, AZ, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Dr. An-Chi Tien, Pharmacodynamics Core Leader of the Ivy Brain Tumor Center, is a recipient of the American Brain Tumor Association’s Discovery Grant,...
Clinical Research Market Research Report [2022-2030] | Industry Size, Market Share, Growth Rate| Business Strategies, Revenue, Opportunities, Future Trends, Key Players, Analysis and Forecast | JC MARKET RESEARCH
November 08, 2022 15:32 ET
|
JC Market Research
Pune, Nov. 08, 2022 (GLOBE NEWSWIRE) -- “Glоbаl Clinical Research Маrkеt” іѕ thе tіtlе оf а rесеntlу рublіѕhеd rероrt bу JCMR market research. Тhе rеѕеаrсh study іnvоlvеd ехреrt оріnіоn and with the...
CROs (Clinical Research Organizations) Training Course: Identification, Selection, and Management for Maximum Results & Value (December 1-2, 2022)
November 01, 2022 05:13 ET
|
Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "CROs (Clinical Research Organizations) - Identification, Selection, and Management for Maximum Results & Value" training has been added to ...